For instance, Novo Nordisk is seeking to enroll 2,500 people for a study of how its brand-name GLP-1 medication, Wegovy, is being used in the real world
For those seeking more modest amounts of weight loss, any of the currently available medications are likely to work and the choice can be driven by a variety of factors: insurance coverage, availability, formulation (injection vs oral), and ease of access and use
Reconstitution should be performed using appropriate laboratory-grade diluents under controlled conditions to maintain peptide integrity and consistency throughout handling
Still, the silver lining for Novo Nordisk is that it has shown that an amylin drug can lead to weight loss, Hsieh says
Patients returning to activities they had been avoiding due to pain or limited function